Samsrita Labs
Close ·
- P/E
- Not meaningful: loss-making over the last twelve months
Key Fundamentals
MicrocapHealthcare ServicesHealthcarePrice-based figures at the close · EPS basis: Consolidated · TTM
- ROCE
- −62.40%
- Debt to Equity
- 0.14
- EPS (TTM)
- −₹3.58
- Book Value
- ₹5.17
- Market Cap
- —
- P/E (TTM)
- Not meaningful: loss-making over the last twelve months
- P/B
- 2.31
- ROE
- −68.80%
- Dividend Yield
- 0.00%
- EBITDA
- −₹8.70 Cr
- 52W High
- ₹25.27
- 52W Low
- ₹10.15
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 75/100
Category scores
- Quality
- 13
- Poor
- Returns, margins, earnings quality 24% weight
- Valuation
- 39
- Weak
- Cheap vs sector & own history 26% weight
- Financial Health
- 48
- Average
- Solvency, leverage, coverage 10% weight
- Momentum
- 18
- Poor
- Trend strength, vol-adjusted 13% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 26% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company has reduced debt.
Weaknesses
5- Company has low interest coverage ratio.
- Promoter holding is low: 25.4%
- Company has a low return on equity of -23.9% over last 3 years.
- Company has high debtors of 365 days.
- Promoter holding has decreased over last 3 years: -27.4%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 7 | 2 |
| Oscillators | Bearish | 2 | 7 | 0 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Bearish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 50.01
- Neutral
- MACD (12,26,9)
- 0.06
- Bearish
- SMA (50)
- 11.82
- Bullish
- SMA (200)
- 14.58
- Bearish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | +14.87% |
|---|---|
| 3Y | 0.00% |
| 1Y | Zero base |
Net profit
| 5Y | Loss widened by ₹7.39 Cr |
|---|---|
| 3Y | Loss widened by ₹7.45 Cr |
| 1Y | Loss widened by ₹7.88 Cr |
Operating cash flow
| 5Y | Outflow widened by ₹3.92 Cr |
|---|---|
| 3Y | Turned negative |
| 1Y | Outflow widened by ₹4.03 Cr |
Operating margin· change in pp
| 5Y | Tiny sales |
|---|---|
| 3Y | Tiny sales |
| 1Y | No sales |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2017 | ₹1.28 Cr |
|---|---|
| Mar 2018 | ₹0.58 Cr |
| Mar 2019 | ₹1.90 Cr |
| Mar 2020 | ₹1.43 Cr |
| Mar 2021 | ₹0.01 Cr |
| Mar 2022 | ₹0.02 Cr |
| Mar 2023 | ₹0.02 Cr |
| Mar 2024 | ₹0.00 Cr |
| Mar 2025 | ₹0.00 Cr |
| Mar 2026 | ₹0.02 Cr |
Net profit by year
| Mar 2017 | −₹1.31 Cr |
|---|---|
| Mar 2018 | −₹1.05 Cr |
| Mar 2019 | −₹2.33 Cr |
| Mar 2020 | −₹1.98 Cr |
| Mar 2021 | −₹0.77 Cr |
| Mar 2022 | ₹1.49 Cr |
| Mar 2023 | −₹0.71 Cr |
| Mar 2024 | −₹0.26 Cr |
| Mar 2025 | −₹0.28 Cr |
| Mar 2026 | −₹8.16 Cr |
Quarterly Results
₹ Cr| Particulars | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2024 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.42 | 0.24 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 | 0 |
| Expenses | 0.89 | 0.76 | 0.32 | 0.35 | 0.23 | 0.07 | 0.08 | 0.06 | 0 | 4.93 | 3.36 | 0.17 | 0.31 |
| Operating Profit | −0.47 | −0.52 | −0.31 | −0.35 | −0.23 | −0.07 | −0.08 | −0.06 | 0 | −4.93 | −3.36 | −0.15 | −0.31 |
| OPM % | −111.9% | −216.67% | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | — | — | — | — | — | — | — | — | −750% | — |
| Other Income | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0 | 0 | 0 | 0.03 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | −0.42 | −0.48 | −0.27 | −0.31 | −0.19 | −0.03 | −0.04 | −0.02 | 0 | −4.93 | −3.36 | −0.12 | −0.31 |
| Tax % | 0% | −14.58% | 0% | −3.23% | 0% | −66.67% | 0% | 0% | — | 0% | 0% | 0% | 0% |
| Net Profit | −0.42 | −0.41 | −0.27 | −0.3 | −0.19 | −0.01 | −0.04 | −0.02 | 0 | −4.55 | −2.94 | −0.48 | −0.19 |
| EPS (₹) | −0.28 | −0.28 | −0.18 | −0.2 | −0.13 | −0.01 | −0.03 | −0.01 | 0 | −2 | −1.29 | −0.21 | −0.08 |
Profit & Loss
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.28 | 0.58 | 1.9 | 1.43 | 0.01 | 0.02 | 0.02 | 0 | 0 | 0.02 | 0.02 |
| Expenses | 1.86 | 1.71 | 4.34 | 3.62 | 0.92 | 0.43 | 1.01 | 0.25 | 0.26 | 8.73 | 8.77 |
| Operating Profit | −0.58 | −1.13 | −2.44 | −2.19 | −0.91 | −0.41 | −0.99 | −0.25 | −0.26 | −8.71 | −8.75 |
| OPM % | −45.31% | −194.83% | −128.42% | −153.15% | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | — | — | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. |
| Other Income | 0.01 | 0.03 | 0.11 | 0.16 | 0.15 | 1.91 | 0.29 | 0 | 0 | 0.03 | 0.03 |
| Interest | 0 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| PBT | −0.58 | −1.11 | −2.36 | −2.06 | −0.77 | 1.49 | −0.7 | −0.25 | −0.26 | −8.68 | −8.72 |
| Tax % | 124.14% | −5.41% | −1.27% | −3.4% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Net Profit | −1.31 | −1.05 | −2.33 | −1.98 | −0.77 | 1.49 | −0.71 | −0.26 | −0.28 | −8.16 | −8.16 |
| EPS (₹) | −1.28 | −0.89 | −1.69 | −1.34 | −0.52 | 1.01 | −0.48 | −0.18 | −0.19 | −3.59 | −3.58 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.26 | 11.76 | 13.81 | 14.81 | 14.81 | 14.81 | 14.81 | 14.81 | 14.81 | 22.75 |
| Reserves | −2.39 | −0.4 | −1.61 | −3.03 | −3.66 | −1.58 | −2.29 | −2.55 | −2.84 | −11 |
| Borrowings | 6.5 | 6.81 | 7.92 | 8.58 | 2.34 | 2.74 | 2.08 | 2.2 | 2.43 | 1.66 |
| Other Liabilities | 4.88 | 4.73 | 6.11 | 7.85 | 3.09 | 1.16 | 0.96 | 1.09 | 1.17 | 0.98 |
| Total Liabilities | 19.25 | 22.9 | 26.23 | 28.21 | 16.58 | 17.13 | 15.56 | 15.55 | 15.57 | 14.39 |
| Fixed Assets | 0.46 | 0.36 | 0.26 | 0.13 | 0.02 | 0.01 | 0.01 | 0.01 | 0 | 0 |
| CWIP | 14.85 | 16.13 | 17.77 | 18.99 | 3.26 | 3.26 | 3.26 | 3.26 | 3.26 | 2 |
| Investments | 0.01 | 0.01 | 0.01 | 0.01 | 4.22 | 4.8 | 4.8 | 4.79 | 4.76 | 9.84 |
| Other Assets | 3.93 | 6.4 | 8.19 | 9.08 | 9.08 | 9.06 | 7.49 | 7.49 | 7.55 | 2.55 |
| Total Assets | 19.25 | 22.9 | 26.23 | 28.21 | 16.58 | 17.13 | 15.56 | 15.55 | 15.57 | 14.39 |
Cash Flow
₹ Cr| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | −0.26 | −3.32 | −2.96 | −1.05 | −0.34 | −0.4 | 0.66 | −0.13 | −0.23 | −4.26 |
| Investing | −1.09 | −1.19 | −1.55 | −1.11 | −0.23 | 0 | 0 | 0 | 0 | 3.26 |
| Financing | 1.27 | 4.83 | 4.19 | 2.17 | 0.55 | 0.4 | −0.67 | 0.13 | 0.22 | 2.63 |
| Net Cash Flow | −0.08 | 0.32 | −0.32 | 0.01 | −0.02 | 0.01 | 0 | 0 | 0 | 1.63 |
| Free Cash Flow | −0.26 | −4.51 | −4.51 | −2.16 | −0.57 | −0.4 | 0.66 | −0.13 | −0.23 | −1 |
| CFO/OP | 45 | 294 | 121 | 48 | 37 | 98 | −67 | 52 | 88 | 49 |
Ratios
| Particulars | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 932 | 1,806 | 425 | 556 | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | — | — | 365 |
| Inventory Days | 0 | — | — | — | — | 0 | 0 | — | — | 0 |
| Cash Conversion Cycle | 932 | 1,806 | 425 | 556 | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | — | — | 365 |
| Working Capital Days | −1,115 | −2,259 | −788 | −1,463 | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. | — | — | Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number. |
| ROCE % | — | −5.44% | −10.11% | −8.45% | −4.07% | 10.12% | −4.58% | −1.72% | −1.8% | −62.42% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Samsrita Labs insights
58 extracted metrics across FY10–FY27.
Documents
- 29 May 2026
- General announcements 12 Oct 2026
- General announcements 10 Oct 2026
Frequently Asked Questions about Samsrita Labs
What does Samsrita Labs Ltd do?
Where is Samsrita Labs Ltd (SAMSRITA) listed?
Which sector does Samsrita Labs Ltd belong to?
What is the 52-week high and low of Samsrita Labs Ltd?
What is the Return on Equity (ROE) of Samsrita Labs Ltd?
Company Information
Incorporated in 1996, Samsarita Labs Ltd is in the business of healthcare services including hospital, diagnostics, Pharma, and Biotechnology (R&D)
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539267.md for Samsrita Labs Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.